Difficulty: Medium
Average Score: 75%
Practice
We have a patient who is diagnosed with variant (vasospastic) angina. Which of the following drugs would be most appropriate, and generally regarded as most effective, for long-term therapy aimed at reducing the incidence or severity of the coronary vasospasm?
Correct answer
D
Rationale
In the context of variant (vasospastic) angina, the most appropriate and effective long-term therapy for reducing coronary vasospasm is nitroglycerin (Option D). Nitroglycerin is a vasodilator that acts by relaxing smooth muscle in blood vessels, including those in the coronary arteries. This vasodilation helps to increase blood flow to the heart muscle, reducing the incidence and severity of vasospasms.
Aspirin (Option A) is commonly used for its antiplatelet effects in preventing thrombus formation but does not directly address vasospasm in variant angina. Atorvastatin (Option B) is a statin used to lower cholesterol levels and reduce the risk of atherosclerosis-related events, not specifically targeting vasospasm. Propranolol (Option C) is a beta-blocker that helps reduce heart rate and blood pressure, but it is not the first-line choice for variant angina.
In an educational context, understanding the mechanism of action of each drug is crucial for selecting the appropriate pharmacological treatment for variant angina. Nitroglycerin's vasodilatory effects directly target the underlying cause of vasospasms in this condition, making it the preferred choice for long-term therapy in this scenario. Students should grasp the rationale behind drug selection based on the pathophysiology of the condition to provide optimal patient care.
Aspirin (Option A) is commonly used for its antiplatelet effects in preventing thrombus formation but does not directly address vasospasm in variant angina. Atorvastatin (Option B) is a statin used to lower cholesterol levels and reduce the risk of atherosclerosis-related events, not specifically targeting vasospasm. Propranolol (Option C) is a beta-blocker that helps reduce heart rate and blood pressure, but it is not the first-line choice for variant angina.
In an educational context, understanding the mechanism of action of each drug is crucial for selecting the appropriate pharmacological treatment for variant angina. Nitroglycerin's vasodilatory effects directly target the underlying cause of vasospasms in this condition, making it the preferred choice for long-term therapy in this scenario. Students should grasp the rationale behind drug selection based on the pathophysiology of the condition to provide optimal patient care.